Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaiser Pharmaceutical Co., Ltd. (KPCC) is a premier manufacturer of concentrated herbal extracts and Traditional Chinese Medicine (TCM) products headquartered in Taiwan. Established in 1969, the company utilizes advanced extraction, concentration, and granulation technologies to produce standardized herbal medicines in various forms, including granules, capsules, and tablets. KPCC is recognized for its commitment to quality, maintaining PIC/S GMP certification and utilizing sophisticated analytical techniques like HPLC to ensure product consistency and safety. The company's products are distributed globally to healthcare practitioners and pharmacies, supporting a wide range of therapeutic applications within the botanical medicine sector. KPCC is a pioneer in the modernization of TCM, combining traditional knowledge with modern scientific manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaiser Pharmaceuticals.